Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1

Human immunodeficiency virus type 1 (HIV-1)-infected individuals who develop drug-resistant virus during antiretroviral therapy may derive benefit from continued treatment for two reasons. First, drug-resistant viruses can retain partial susceptibility to the drug combination. Second, therapy select...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	J Virol
المؤلفون الرئيسيون:	Zhang, Haili, Zhou, Yan, Alcock, Cecily, Kiefer, Tara, Monie, Daphne, Siliciano, Janet, Li, Quan, Pham, Paul, Cofrancesco, Joseph, Persaud, Deborah, Siliciano, Robert F.
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	American Society for Microbiology (ASM) 2004
الموضوعات:	Vaccines and Antiviral Agents
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369469/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14747537/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.4.1718-1729.2004
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!